In addition to its peripheral actions, l-NAME reportedly crosses the blood–brain barrier (BBB) to decrease NOS expression and inhibit NOS activity in brain [22,23,24], leading to brain-initiated hypertension. This evidence concerns the gene NOS1 and hypertensive disorder.